The speculative purchases of investors have no brake on the pharmaceutical company responsible for the only marketed vaccine that includes monkeypox among its indications.
The precedent of the coronavirus gives free rein to purchases with a more speculative profile on the stock market related to the latest health threat that is beginning to spread through the West, monkeypox. The confirmation of positive cases in
5
